Cognito Appoints New VP to Financial Communications Practice
Taylor Fenske joins financial services agency as Vice President; Andrew Marshall relocates to New York…
Taylor Fenske joins financial services agency as Vice President; Andrew Marshall relocates to New York…
Full-year backlog growth of 19% with Forged Engineered Products backlog up 319% Full-year sales growth…
AUSTIN, Texas–(BUSINESS WIRE)–E2open Parent Holdings, Inc. (NYSE: ETWO), a leading network-based provider of a cloud-based,…
Continued Growth in Q4 Solidified #1 Ranking for the Year FOUNTAIN VALLEY, Calif.–(BUSINESS WIRE)–#KingstonIsWithYou–Kingston Digital,…
Sensata’s new tire Tread Depth Monitoring (TDM) solution, powered by NIRA Dynamics’ tread wear estimation…
Backed by Web3 Investors, Including ParaFi Capital, Digital Currency Group and Multicoin Capital, OXIO Raises…
MAINZ, GERMANY, March 16, 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the…
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
PASADENA, CA, March 16, 2022 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage…
-Establishing the Camelina crop as a replenishable reserve of feedstock oil for biofuels -Winter Camelina…
ANAHEIM, CA, March 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”),…
Plans to present data at multiple scientific conferences in 2022 Expects to file INDs for…
Glen Rock, N.J., March 16, 2022 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or…
BOSTON, March 16, 2022 (GLOBE NEWSWIRE) — Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:…
VANCOUVER, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
CAMBRIDGE, Mass., March 16, 2022 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)…
AVENTURA, Fla. and NATICK, Mass., March 16, 2022 (GLOBE NEWSWIRE) — Cytovia Therapeutics, Inc., a biopharmaceutical…
Data from Pooled-Analysis of Enteral Protease Inhibitor LB1148 Demonstrated 72% Reduction in the Risk of…
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
Oral presentation will focus on interim efficacy and safety data from the Phase 1/1b AURELIO-03…